Recent reviews have demonstrated that many cancers have increased mTOR activity due to deregulation of upstream and downstream mTOR signal pathways (Blenis, 2017; Saxton and Sabatini, 2017; Seeboeck et al., 2019). Here, MTOR is linked to cancer.